文献速递血栓与止血

妊娠期及产后2B型血管性血友病女性的管理挑战:来自文献、国际登记处和医师调查的证据——国际血栓与止血学会科学与标准化委员会的通讯

Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians' survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis.
PubMed 文献 · J Thromb Haemost · 2022-12-22

本文通过文献回顾、国际登记处和医师调查三种途径,收集全球49名女性55次妊娠(文献35次、登记处20次)及112名医师报告的数据,描述迄今最大的2B型血管性血友病妊娠数据集。数据凸显出血并发症仍是关切、目标安全血管性血友病因子水平及理想监测方法未知、止血管理实践差异大、医师对分娩方式和椎管内麻醉使用观点不一。作者结论认为亟需国际共识和指导以改善该患者群体的护理和结局。

要点

  • 出血并发症仍是2B型血管性血友病妊娠患者的关切问题。
  • 目标安全血管性血友病因子水平和理想监测方法尚不明确。
  • 止血管理的治疗类型和时机实践差异大,医师对分娩方式和椎管内麻醉观点不一。

核心结论

  • 作者结论认为亟需国际共识和指导以改善该患者群体的护理和结局。

研究设计与样本

  • 通过文献回顾、国际登记处和关于医师实践的國際调查三种途径收集数据,登记处和调查由国际血栓与止血学会支持。
  • 分析全球49名女性共55次妊娠(文献35次、登记处20次)的临床和实验室特征、管理、出血并发症及妊娠结局数据,以及112名医师报告的数据。

主要发现

  • 出血并发症仍是这些患者的关切问题。
  • 目标安全血管性血友病因子水平和理想监测方法未知。
  • 止血管理在治疗类型和时机上实践范围广泛。
  • 医师对分娩方式和椎管内麻醉使用有不同观点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of women with type 2B von Willebrand disease (VWD) during pregnancy is challenging because of dysfunctional von Willebrand factor (VWF) and the complexity resulting from discrepant VWF/factor VIII (VWF/FVIII) levels, impaired platelet-dependent VWF activity, progressive thrombocytopenia, and risks associated with the use of desmopressin. There is a lack of high-quality evidence to support clinical decision making. OBJECTIVES: In this study, we examined the current diagnostic and management approaches and outcomes in women with VWD during pregnancy. METHODS: Data were collected via 3 avenues: literature review, an international registry, and an international survey on physicians' practices for the management of pregnancy in women with VWD. The registry and survey were supported by the International Society on Thrombosis and Haemostasis. RESULTS: Data on clinical and laboratory features, management and bleeding complications, and pregnancy outcomes of a total of 55 pregnancies from 49 women across the globe (literature: 35, registry: 20) and data reported by 112 physicians were analyzed. We describe the largest dataset on pregnancies in women with type 2B VWD available to date. The data highlight the following key issues: a) bleeding complications remain a concern in these patients, b) the target safe VWF level and the ideal monitoring approach are unknown, c) there is a wide range of hemostatic management practices in the type and timing of treatment, and d) physicians have diverse views on the mode of delivery and use of neuraxial anesthesia. CONCLUSION: We conclude that an international consensus and guidance are critically required for better care and improved outcomes in this patient cohort.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Miljic P, Noureldin A, Lavin M, et al. Challenges in the management of women with type 2B von Willebrand disease during pregnancy and the postpartum period: evidence from literature and data from an international registry and physicians' survey-communication from the Scientific and Standardization Committees of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2022. PMID: 36695378. doi:10.1016/j.jtha.2022.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。